Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.

Biologicals : journal of the International Association of Biological Standardization - 1 Dec 1999

Cuypers H T, van Dijk R, Viret J F, Schottstedt V, Lankinen M, Da Silva Cardoso M, Lelie P N

Abstract excerpt

The NucliSens Extractor in combination with the 2.0 version of the Roche Cobas HCV Amplicor test has been validated by five European blood screening laboratories in a multi-centre study. For testing the performance characteristics of this HCV-NAT method, the European Pharmacopoeia validation guidelines were followed. The CLB VQC reference reagents were used for testing robustness and sensitivity. After a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Europe
Share to Evaluation Studies as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Guidelines as Topic

Share to Hepacivirus

Share to Nucleic Acid Amplification Techniques

Share to Plasma

Share to Reference Standards

Share to World Health Organization

Source

Identifiers

PMID: 10686057
DOI: 10.1006/biol.1999.0225

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

European multi-centre validation study of NucliSens Extractor in combination with HCV Amplicor 2.0 assay for HCV-NAT screening of plasma pools.PMID 10686057Read ↗

Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.Semantic proximity Read ↗

Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.Semantic proximity Read ↗

Sensitivity of HCV RNA and HIV RNA blood screening assays.Semantic proximity Read ↗

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group.Semantic proximity Read ↗

Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture.Semantic proximity Read ↗

Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA.Semantic proximity Read ↗

Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods.Semantic proximity Read ↗

Evaluation of a new NASBA assay for the qualitative detection of hepatitis C virus based on the NucliSens Basic Kit reagents.Semantic proximity Read ↗

Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.Semantic proximity Read ↗

High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology.Semantic proximity Read ↗

Evaluation of the NucliSens EasyQ v2.0 assay in comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in quantification of C-clade HIV-1 in plasma.Semantic proximity Read ↗

First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.